These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27751772)

  • 21. Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health.
    Sun Q; Tärnberg M; Zhao L; Stålsby Lundborg C; Song Y; Grape M; Nilsson M; Tomson G; Nilsson LE
    PLoS One; 2014; 9(11):e113121. PubMed ID: 25405340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel.
    Buchek G; Mende K; Telu K; Kaiser S; Fraser J; Mitra I; Stam J; Lalani T; Tribble D; Yun HC
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33675647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
    van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.
    Zhao SY; Zhang J; Zhang YL; Wang YC; Xiao SZ; Gu FF; Guo XK; Ni YX; Han LZ
    Epidemiol Infect; 2016 Mar; 144(4):695-702. PubMed ID: 26260355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities.
    Luvsansharav UO; Hirai I; Nakata A; Imura K; Yamauchi K; Niki M; Komalamisra C; Kusolsuk T; Yamamoto Y
    J Antimicrob Chemother; 2012 Jul; 67(7):1769-74. PubMed ID: 22514260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and Risk Factors for Acquisition of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Newborns in Seville, Spain: A Prospective Cohort Study.
    Rodríguez-Revuelta MJ; López-Cerero L; Serrano L; Luna-Lagares S; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2018 Dec; 52(6):835-841. PubMed ID: 30236957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intense pre-admission carriage and further acquisition of ESBL-producing Enterobacteriaceae among patients and their caregivers in a tertiary hospital in Rwanda.
    Kurz MS; Bayingana C; Ndoli JM; Sendegeya A; Durst A; Pfüller R; Gahutu JB; Mockenhaupt FP
    Trop Med Int Health; 2017 Feb; 22(2):210-220. PubMed ID: 27935649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.
    Karanika S; Karantanos T; Arvanitis M; Grigoras C; Mylonakis E
    Clin Infect Dis; 2016 Aug; 63(3):310-8. PubMed ID: 27143671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of Intestinal Carriage of Extended-Spectrum Beta-lactamase-Producing Enterobacteriaceae in the Dutch General Population, 2014-2016.
    van den Bunt G; Fluit AC; Bootsma MCJ; van Duijkeren E; Scharringa J; van Pelt W; Bonten MJM
    Clin Infect Dis; 2020 Nov; 71(8):1847-1855. PubMed ID: 31688916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying within-household transmission of extended-spectrum β-lactamase-producing bacteria.
    Haverkate MR; Platteel TN; Fluit AC; Cohen Stuart JW; Leverstein-van Hall MA; Thijsen SFT; Scharringa J; Kloosterman RC; Bonten MJM; Bootsma MCJ
    Clin Microbiol Infect; 2017 Jan; 23(1):46.e1-46.e7. PubMed ID: 27596534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
    Brown DG; Worby CJ; Pender MA; Brintz BJ; Ryan ET; Sridhar S; Oliver E; Harris JB; Turbett SE; Rao SR; Earl AM; LaRocque RC; Leung DT
    J Travel Med; 2023 Oct; 30(6):. PubMed ID: 36864572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.
    Schaumburg F; Alabi A; Kokou C; Grobusch MP; Köck R; Kaba H; Becker K; Adegnika AA; Kremsner PG; Peters G; Mellmann A
    J Antimicrob Chemother; 2013 Sep; 68(9):2140-3. PubMed ID: 23645586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.
    Tham J; Walder M; Melander E; Odenholt I
    Scand J Infect Dis; 2012 Aug; 44(8):573-7. PubMed ID: 22292796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
    Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
    Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.
    Islam S; Selvarangan R; Kanwar N; McHenry R; Chappell JD; Halasa N; Wikswo ME; Payne DC; Azimi PH; McDonald LC; Gomez-Duarte OG
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):234-240. PubMed ID: 28992133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
    Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
    Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis.
    Jørgensen SB; Samuelsen O; Sundsfjord A; Bhatti SA; Jørgensen I; Sivapathasundaram T; Leegaard TM
    Scand J Infect Dis; 2014 Jun; 46(6):462-5. PubMed ID: 24702690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives.
    Valverde A; Turrientes MC; Norman F; San Martín E; Moreno L; Pérez-Molina JA; López-Vélez R; Cantón R
    Clin Microbiol Infect; 2015 Mar; 21(3):252.e1-4. PubMed ID: 25658550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
    Jolivet S; Vaillant L; Poncin T; Lolom I; Gaudonnet Y; Rondinaud E; Bendjelloul G; Lomont A; Lucet JC; Armand-Lefèvre L
    Clin Microbiol Infect; 2018 Dec; 24(12):1311-1314. PubMed ID: 29549056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.
    Tham J; Odenholt I; Walder M; Brolund A; Ahl J; Melander E
    Scand J Infect Dis; 2010 Apr; 42(4):275-80. PubMed ID: 20121649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.